NRG Oncology

Research at #ASTRO23

NRG Oncology will have 20 presentations at ASTRO's Annual Meeting, held October 1-4, 2023, in San Diego, including a Master Class, two plenary presentations, four Presidential Symposium sessions, and eight oral presentations.

Special Sessions: Sunday, October 1, 2023; 12pm - 4pm PT; San Diego Convention Center / Ballroom 20


  • Presidential Symposium Session I: Clinical Trial Design Moderator: James Dignam, PhD


  • Presidential Symposium Session II: Diversity in Clinical Trials Moderator: Eleanor Walker, MD


  • Presidential Symposium Session III: Patient Perspectives Moderators: Bryan Hwang, MD; Barbara Barclay, Patient Advocate


  • Presidential Symposium Session IV: International Trial Reports Moderator: Mitchell Machtay, MD


Master Class: Sunday, October 1, 2023; 4:57-5:17pm PT; Room 30 A/B/C

Beyond RTOGv2.0: The First Ten Years of NRG Oncology and Paying It Forward for Many Years Ahead 

Session Chairs: Quynh Le, MD and Mitch Machtay 

Speakers: Kristin Higgins, MD and Vinai Gondi, MD 


Plenary Sessions: Monday, October 2, 2023; 1:30-3pm PT; San Diego Convention Center / Ballroom 20


  • Primary endpoint results of NRG CC003: Phase IIR/III trial of prophylactic cranial irradiation (PCI) with or without hippocampal avoidance (HA) for small cell lung cancer (SCLC) Presenter: Vinai Gondi, MD 


  • Randomized phase III trial of postoperative radiotherapy with or without cetuximab for intermediate-risk squamous cell carcinoma of the head and neck (SCCHN): NRG/RTOG 0920  Presenter: Mitchell Machtay, MD

View the flyer posted on the NRG Oncology website for the complete presentation schedule of NRG Oncology Research.

View the Flyer
Twitter      Facebook      Instagram      LinkedIn      YouTube